Triumvira.com

Bayer and Northpond Ventures Lead USD $55 Million Series A

WEBLEVERKUSEN, Germany & AUSTIN, Texas–(BUSINESS WIRE)–Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel …

Actived: 5 days ago

URL: https://triumvira.com/bayer-and-northpond-ventures-lead-usd-55-million-series-a-financing-round-for-triumvira-immunologics-2/

Triumvira Announces Addition of Veteran VP of Regulatory Affairs

WEBAUSTIN, TX, and HAMILTON, ON, March 13, 2019 – Triumvira Immunologics, Inc., (Triumvira) a privately held biopharmaceutical company developing …

Category: Health Go Health

Triumvira Immunologics – T-Cell Therapeutics

WEBIn this Health Professional Radio interview – Learn how Triumvira Immunologics is developing novel T-Cell therapies to treat cancer patients. Discover …

Category: Cancer Go Health

Triumvira Announces Grant of T Cell Antigen Coupler (TAC) …

WEBAUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics Inc. (Triumvira), a privately-held biopharmaceutical company developing a …

Category: Health Go Health

Triumvira Immunologics Appoints Cynthia Collins to Board of …

WEBInnovative immuno-therapy company welcomes a recognized leader in life sciences and therapeutics AUSTIN, Texas & TORONTO–(BUSINESS WIRE)–Triumvira …

Category: Health Go Health

LaVoieHealthScience Expands Senior Leadership Team, Adds Two …

WEBDouglas Russell joins LHS as Senior Vice President & General Manager. BOSTON–(BUSINESS WIRE)–LaVoieHealthScience (LHS), an integrated investor and …

Category: Health Go Health

Press Releases & News Archives

WEBAUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics (Triumvira), a privately-held biopharmaceutical company developing a novel platform for …

Category: Health Go Health

The Top 25 Healthcare Technology Leaders of Austin for 2023

WEBFrom The Healthcare Technology Report The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Austin for …

Category: Health Go Health

TAC101-Claudin18.2 Clinical Trials

WEBDose Expansion Phase . Indication cohorts: 1) CLDN18.2+ gastric and esophageal adenocarcinoma 2) CLDN18.2+ pancreatic ductal adenocarcinoma 3) CLDN18.2+ …

Category: Health Go Health

A Phase I/II Trial Investigating Safety and Efficacy of

WEBA Phase I/II Trial Investigating Safety and Efficacy of Autologous T Cell Antigen-Coupler (TAC) T Cells Targeting HER2 in Relapsed or Refractory Solid Tumors (TACTIC-2).

Category: Health Go Health

triumvira1, Author at Triumvira Immunologics Car-T, TCR, TAC

WEBNovel CLDN18.2-TAC T cell candidate effectively eradicated Claudin 18.2-expressing gastric tumor cells in vitro and in vivo. AUSTIN, Texas, and HAMILTON, …

Category: Health Go Health

Board of Directors Archives

WEBMs. Williams has nearly 20 years of experience in biotech, working with publicly listed entities in both Canada and the United States. Ms. Williams is currently the CFO of …

Category: Health Go Health

Connor McDermott

WEBConnor McDermott is a Vice President at Northpond Ventures where he evaluates and supports biotechnology companies. Connor joined Northpond in 2019 as a member of …

Category: Health Go Health

triumvira1, Author at Triumvira Immunologics Car-T, TCR, TAC

WEBInnovative immuno-therapy company welcomes proven leaders in pharma and therapeutics. AUSTIN, Texas & HAMILTON, Ontario – Triumvira Immunologics, a privately held …

Category: Health Go Health